首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold
【2h】

Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold

机译:黄病毒蛋白酶调控和特异性以及黄病毒科折叠进化的结构证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pathogenic members of the flavivirus family, including West Nile Virus (WNV) and Dengue Virus (DV), are growing global threats for which there are no specific treatments. The two-component flaviviral enzyme NS2B-NS3 cleaves the viral polyprotein precursor within the host cell, a process that is required for viral replication. Here, we report the crystal structure of WNV NS2B-NS3pro both in a substrate-free form and in complex with the trypsin inhibitor aprotinin/BPTI. We show that aprotinin binds in a substrate-mimetic fashion in which the productive conformation of the protease is fully formed, providing evidence for an “induced fit” mechanism of catalysis and allowing us to rationalize the distinct substrate specificities of WNV and DV proteases. We also show that the NS2B cofactor of WNV can adopt two very distinct conformations and that this is likely to be a general feature of flaviviral proteases, providing further opportunities for regulation. Finally, by comparing the flaviviral proteases with the more distantly related Hepatitis C virus, we provide insights into the evolution of the Flaviviridae fold. Our work should expedite the design of protease inhibitors to treat a range of flaviviral infections.
机译:黄病毒家族的致病成员,包括西尼罗河病毒(WNV)和登革热病毒(DV),正在成为全球性威胁,目前尚无针对性的治疗方法。两组分黄病毒酶NS2B-NS3裂解宿主细胞内的病毒多蛋白前体,这是病毒复制所必需的过程。在这里,我们报告WNV NS2B-NS3pro的晶体结构,无底物形式和与胰蛋白酶抑制剂抑肽酶/ BPTI的复合物。我们显示抑肽酶以底物模拟方式结合,其中蛋白酶的生产构象完全形成,从而为催化的“诱导拟合”机制提供了证据,并使我们能够合理化WNV和DV蛋白酶的独特底物特异性。我们还表明,WNV的NS2B辅因子可以采用两个非常不同的构象,这很可能是黄病毒蛋白酶的一般特征,为调节提供了更多机会。最后,通过将黄病毒蛋白酶与更远距离相关的丙型肝炎病毒进行比较,我们提供了黄病毒科折叠进化的见解。我们的工作应加快蛋白酶抑制剂的设计,以治疗一系列黄病毒感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号